CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence

BACKGROUND: Multiple early gastric cancers (EGCs) may develop in 6–14% of patients even after achieving curative endoscopic submucosal dissection (ESD); however, a useful biomarker for predicting recurrence is not available. The present study investigated whether the expression of CD44 variant 9 (CD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hirata, K, Suzuki, H, Imaeda, H, Matsuzaki, J, Tsugawa, H, Nagano, O, Asakura, K, Saya, H, Hibi, T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3721391/
https://ncbi.nlm.nih.gov/pubmed/23778530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.314
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados